Title

Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA study): overall survival results from a randomised, double-blind, placebo-controlled, phase 3 study.

Document Type

Journal Article

Publication Date

5-2013

Journal

The Lancet Oncology

Volume

Volume 14, Issue 6

Inclusive Pages

461-471

Keywords

Antineoplastic Combined Chemotherapy Protocols--therapeutic use; Breast Neoplasms--drug therapy; Molecular Targeted Therapy--methods; Receptor; erbB-2--antagonists & inhibitors; Tumor Markers; Biological--antagonists & inhibitors

Peer Reviewed

1